Combination therapy with thymosin α1 potentiates the anti-tumor activity of interleukin-2 with cyclophosphamide in the treatment of the lewis lung carcinoma in mice-Reference-Cited by-同舟云学术

Combination therapy with thymosin α1 potentiates the anti-tumor activity of interleukin-2 with cyclophosphamide in the treatment of the lewis lung carcinoma in mice

Published:1992-02-01 Issue:3 Volume:50 Page:493-499
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Mastino Antonio,Favalli Cartesio,Grelli Sandro,Rasi Guido,Pica Francesca,Goldstein Allan L.,Garaci Enrico

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference31 articles.

1. Modulation of natural killer activity by thymosin alpha 1 and interferon

2. Synergistic effect of thymosin α1 and αβ-interferon on NK activity in tumor-bearing mice

3. Tumor Immunotherapy by Local Injection of Interleukin 2 and Non-Reactive Lymphocytes

4. Combination treatment using thymosin α1 and interferon after cyclophosphamide is able to cure Lewis lung carcinoma in mice

5. Thymosin alpha1: isolation and sequence analysis of an immunologically active thymic polypeptide.

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phenotypic drug discovery: a case for thymosin alpha-1;Frontiers in Medicine;2024-06-06

2. Mechanism and clinical application of thymosin in the treatment of lung cancer;Frontiers in Immunology;2023-08-28

3. Thymus-derived hormonal and cellular control of cancer;Frontiers in Endocrinology;2023-07-17

4. Thymosin α1 interacts with Galectin-1 modulating the β-galactosides affinity and inducing alteration in the biological activity;International Immunopharmacology;2023-05

5. A Case Report of Partial Remission of End-stage Pancreatic Cancer Patient with Liver Metastasis Treated with Chemotherapy and Integrated Medicine Therapy;The Journal of Internal Korean Medicine;2020-05-30